Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by upinzmokeon Jan 11, 2017 7:03pm
138 Views
Post# 25696786

RE:RE:RE:RE:RE:RE:So APH has less sales than Mettrum and trades double

RE:RE:RE:RE:RE:RE:So APH has less sales than Mettrum and trades double No one can say for sure,(except maybe the parties involved) how med mj will be sold ,by who,
and the suppliers.
 To assume Drug stores will only retial product from only 1 LP is a bit reduculous...
Shoppers, London Drugs, Pharma plus wil have availibility from most LPs as it will be the
patient/customer who ulitmaetly decides if they want product from aphria ,aurora,tweed,
Ogi or any of the other LPs. As long as the product meets the prescription requirements


A bit of common sense dictates here.
My guess is all LPs will be able to sell more then thier fair share of MMJ in Canada
and all of them will be prosper>>>>>

Bullboard Posts